0001567619-21-008605.txt : 20210426
0001567619-21-008605.hdr.sgml : 20210426
20210426180540
ACCESSION NUMBER: 0001567619-21-008605
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210416
FILED AS OF DATE: 20210426
DATE AS OF CHANGE: 20210426
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Williams Caroline C
CENTRAL INDEX KEY: 0001858103
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36268
FILM NUMBER: 21855291
MAIL ADDRESS:
STREET 1: 324 SOUTH HYDE PARK AVENUE, SUITE 350
CITY: TAMPA
STATE: FL
ZIP: 33606
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MyMD Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001321834
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1185 AVENUE OF THE AMERICAS
STREET 2: 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 856-848-8698
MAIL ADDRESS:
STREET 1: 1185 AVENUE OF THE AMERICAS
STREET 2: 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
FORMER COMPANY:
FORMER CONFORMED NAME: Akers Biosciences, Inc.
DATE OF NAME CHANGE: 20170413
FORMER COMPANY:
FORMER CONFORMED NAME: Akers Biosciences Inc
DATE OF NAME CHANGE: 20050325
3
1
doc1.xml
FORM 3
X0206
3
2021-04-16
0
0001321834
MyMD Pharmaceuticals, Inc.
MYMD
0001858103
Williams Caroline C
1185 AVENUE OF THE AMERICAS, 3RD FLOOR
NEW YORK
NY
10036
0
0
1
0
Common Stock
1272972
D
Common Stock
2471479
I
The Starwood Trust
Common Stock
1272972
I
Caroline Constance Williams 2021 Irrevocable Trust
Stock Option (Right to Buy)
2023-04-16
Common Stock
1275731
I
The Starwood Trust
Received in exchange for shares of a private company formerly known as "MyMD Pharmaceuticals, Inc." (the "Former Entity") in connection with the merger of the Former Entity with a wholly owned subsidiary of the Issuer (the "Merger"). On the effective date of the Merger, the closing price of the Issuer's common stock was $4.94 per share (after giving effect to a reverse stock split on April 19, 2021).
The reporting person is a trustee of the trust and a beneficiary of the trust. The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.
The reporting person is a beneficiary of the trust but not a trustee. The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.
These options are fully vested and exercisable.
Received in the Merger in exchange for a stock option to acquire shares of the Former Entity at $1.00 per share.
/s/ Caroline C. Williams
2021-04-26